Systematic Evaluation of AML-Associated Antigens Identifies Anti-U5 SNRNP200 Therapeutic Antibodies for the Treatment of Acute Myeloid Leukemia

High-density immunophenotyping of AML coupled with proteogenomics identified unique expression of a variety of antigens, including the RNA helicase U5 snRNP200, on the surface of AML cells.